| Literature DB >> 32321442 |
Zixin Wang1,2, Phoenix K H Mo3, Mary Ip3, Yuan Fang4, Joseph T F Lau3,5.
Abstract
BACKGROUND: Sexualized drug use (SDU) refers to use of any psychoactive substance before/during sexual intercourse. Chemsex is a subset of SDU, which is defined as the use of some specific psychoactive substances (methamphetamine, mephedrone, γ-hydroxybutyrate, ketamine and cocaine) before/during sexual intercourse. SDU and chemsex are prevalent among gay, bisexual and other men who have sex with men (GBMSM). This study investigated uptake and willingness to use pre-exposure prophylaxis (PrEP) among a sample of GBMSM in Hong Kong with experience of SDU in the past year.Entities:
Keywords: China; Gay, bisexual and other men who have sex with men; Pre-exposure prophylaxis; Sexualized drug use; Willingness to use
Mesh:
Substances:
Year: 2020 PMID: 32321442 PMCID: PMC7178573 DOI: 10.1186/s12879-020-05024-4
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Characteristics of GBMSM with and without experience of sexualized drug use (SDU) in the past year
| All | Without experience of SDU in the past year | With experience of SDU in the past year ( | With vs. without experience of SDU in the past year | ||
|---|---|---|---|---|---|
| % | % | % | OR (95%CI) | AOR (95%CI) | |
| Age group | |||||
| 18–30 | 56.6 | 57.6 | 50.0 | 1.0 | |
| 31–40 | 31.6 | 30.5 | 37.8 | 1.43 (0.86, 2.37) | |
| > 40 | 11.9 | 11.8 | 12.2 | 1.19 (0.56, 2.50) | |
| Highest educational level attained | |||||
| Senior high or below | 15.5 | 14.3 | 23.2 | 1.0 | 1.0 |
| College or above | 84.5 | 85.7 | 76.8 | ||
| Current marital status | |||||
| Currently single | 84.0 | 84.9 | 78.0 | 1.0 | |
| Married/cohabited with a man | 15.7 | 14.7 | 19.8 | 1.63 (0.91, 2.91)† | |
| Married/cohabited with a woman | 0.3 | 0.4 | 0.0 | N.A. | – |
| Monthly personal income (HK$) | |||||
| < 10,000 | 13.4 | 12.7 | 18.3 | 1.0 | |
| 10,000-19,999 | 29.1 | 28.1 | 35.4 | 0.87 (0.44, 1.74) | |
| 20,000-39,999 | 36.7 | 37.8 | 30.5 | 0.56 (0.28, 1.13) | |
| 40,000 and above | 19.7 | 20.5 | 14.6 | 0.49 (0.22, 1.12)† | |
| Refuse to disclose | 1.0 | 1.0 | 1.2 | 0.84 (0.09, 7.73) | – |
| Current employment status | |||||
| Full-time | 83.6 | 85.1 | 74.4 | 1.0 | 1.0 |
| Part-time/unemployed/retired/ students | 16.4 | 14.9 | 25.6 | 1.37 (0.74, 2.56) | |
| Sexual orientation | |||||
| Homosexual | 90.7 | 90.4 | 92.7 | 1.0 | |
| Bisexual | 8.4 | 8.6 | 7.3 | 0.83 (0.34, 2.01) | |
| Heterosexual | 0.9 | 1.0 | 0.0 | N.A. | – |
| Channels of recruitment | |||||
| Outreach in gay venues | 14.1 | 13.3 | 19.5 | 1.0 | |
| Online recruitment | 57.6 | 58.6 | 51.2 | 0.59 (0.31, 1.12) | |
| Peer referral | 28.3 | 28.1 | 29.3 | 0.71 (0.35, 1.42) | – |
| HIV testing in the last 12 months | |||||
| No | 28.4 | 29.9 | 19.5 | 1.0 | |
| Yes | 71.6 | 70.1 | 80.5 | 1.76 (0.99, 3.14)† | – |
| Other HIV prevention services in the last 12 months (e.g., condom distribution, peer education, pamphlet and lectures) | |||||
| No | 44.7 | 46.8 | 31.7 | 1.0 | 1.0 |
| Yes | 55.3 | 53.2 | 68.3 | ||
| History of sexually transmitted infections other than HIV | |||||
| No | 80.5 | 82.9 | 65.9 | 1.0 | 1.0 |
| Yes | 19.5 | 17.1 | 34.1 | 1.72 (0.97, 3.07)† | |
| Had had anal intercourse with regular male sex partners (RP) | |||||
| No | 14.7 | 13.5 | 22.0 | 1.0 | 1.0 |
| Yes | 85.3 | 86.5 | 78.0 | 0.90 (0.46, 1.73) | |
| Had had anal intercourse with non-regular male sex partners (NRP) | |||||
| No | 39.1 | 44.0 | 9.8 | 1.0 | 1.0 |
| Yes | 60.9 | 56.0 | 90.2 | ||
| Condomless anal intercourse (CAI) with men | |||||
| No | 60.5 | 63.7 | 41.5 | 1.0 | 1.0 |
| Yes | 39.5 | 36.3 | 58.5 | ||
| Multiple male sex partnerships | |||||
| No | 30.7 | 34.1 | 9.8 | 1.0 | 1.0 |
| Yes | 69.3 | 65.9 | 90.2 | 0.84 (0.25, 2.80) | |
| Currently on PrEP | |||||
| No | 96.0 | 97.8 | 85.4 | 1.0 | 1.0 |
| Yes | 4.0 | 2.2 | 14.6 | ||
| Depressive symptoms | |||||
| No clinical depressive symptoms (CES-D-10 score < 10) | 64.1 | 65.7 | 54.9 | 1.0 | |
| Presence of clinical depressive symptoms (CES-D-10 score ≥ 10) | 35.9 | 34.3 | 45.1 | 1.57 (0.98, 2.52)† | |
| Anxiety | |||||
| No/mild anxiety (GAD-7 score < 15) | 94.0 | 94.4 | 91.5 | 1.0 | |
| Severe anxiety (GAD-7 score ≥ 15) | 6.0 | 5.6 | 8.5 | 1.57 (0.66, 3.72) | |
OR Crude odds ratios
AOR: multivariate odds ratios obtained by multivariate logistic regression using variables in Table 1 that were found to be statistically significant in the univariate analysis as candidates
95%CI 95% confidence interval
† 0.05 < P < 0.10, * P < 0.05, ** P < 0.01, *** P < 0.001
N.A. Not applicable; --: not considered in the model
Patterns of SDU and perceptions related PrEP among GBMSM with experience of SDU in the past year
| % / Mean (SD) | |
|---|---|
| ( | |
| Types of psychoactive substance used during SDU in past year | |
| Ketamine | 1.2 |
| Methamphetamine | 31.7 |
| Cocaine | 1.2 |
| Cannabis | 8.5 |
| Ecstasy | 3.7 |
| Dormicum / Halcion / Erimin 5 / Hypnotic drugs (non-prescription) | 0.0 |
| Heroin | 0.0 |
| Cough suppressant (not for curing cough) | 1.2 |
| Amyl nitrite | 80.5 |
| GHB/GBL | 31.7 |
| 5-methoxy-N, N-diisopropyltryptamine (Foxy) | 4.9 |
| Mephedrone | 0.0 |
| Poly-use of psychoactive substances in lifetime | |
| No | 69.5 |
| Yes | 30.5 |
| Time since the first episode of SDU | |
| < 1 year | 40.2 |
| 1–2 years | 15.9 |
| 3–5 years | 15.9 |
| > 5 years | 28.0 |
| Frequency of SDU in the past year | |
| 1 episode/month | 37.8 |
| 1–2 episodes/month | 29.3 |
| ≥ 3 episodes/month | 32.9 |
| Condomless anal intercourse during SDU in the past year | |
| No | 48.8 |
| Yes | 51.2 |
| Drug cessation/rehabilitation services provided by governmental organizations | |
| No | 97.6 |
| Yes | 2.4 |
| Drug cessation/rehabilitation services provided by non-governmental organizations | |
| No | 90.2 |
| Yes | 9.8 |
| Details of the most recent episode of SDU | |
| Number of participants | |
| 2 | 78.0 |
| ≥ 3 | 22.0 |
| Alcohol consumption | |
| No | 85.4 |
| Yes | 14.6 |
| Use of erectile dysfunction drugs | |
| No | 69.5 |
| Yes | 30.5 |
| Group sex | |
| No | 80.5 |
| Yes | 19.5 |
| Condomless anal intercourse | |
| No | 48.8 |
| Yes | 51.2 |
| ( | |
| Willingness to take once-daily oral pill as PrEP in the next six months after being briefed some facts of PrEP | |
| No (definitely not/probably not/neutral) | 32.9 |
| Yes (probably will/definitely will) | 67.1 |
| Willingness to pay (HK$ per month) for using once-daily oral pill as PrEP (among those with willingness to take PrEP in the next six months, | |
| ≤ 300 | 24.2 |
| 301–500 | 14.3 |
| 501–1000 | 18.6 |
| 1000–2000 | 21.4 |
| 2001–4000 | 17.1 |
| 4001–6000 | 2.9 |
| 6001–8000 | 1.4 |
| > 8000 | 0.0 |
| Perceptions related to PrEP based on the TPB | |
| Positive attitudes toward PrEP (% agree) | |
| PrEP can reduce your chance of HIV infection during SDU | 81.4 |
| PrEP would reduce your worry of HIV infection when having condomless sex during SDU | 64.3 |
| PrEP provides you more choice for HIV prevention | 84.3 |
| 8.1 (1.3) | |
| Negative attitudes toward PrEP (% agree) | |
| Psychoactive substances that are used during SDU would reduce the protective effect of PrEP | 17.1 |
| Psychoactive substances that are used during SDU would aggravate the side-effects of PrEP | 30.0 |
| Psychoactive substances that are used during SDU would make you forget to take PrEP | 28.6 |
| Daily use of PrEP would cause severe financial burden for you | 80.0 |
| You will be stigmatized by medical professionals when you are using PrEP-related services | 37.1 |
| 10.2 (2.2) | |
| Perceived subjective norm related to PrEP | |
| People who are important to you will support you to use PrEP | |
| Disagree/neutral | 32.9 |
| Agree | 67.1 |
| Perceived behavioral control to use PrEP | |
| In general, you are confident in taking PrEP every day in the next six months | |
| Strongly disagree/disagree/neutral | 35.7 |
| Agree/strongly agree | 64.3 |
Sexualized drug use is defined as use of the following psychoactive substances before/during anal intercourse, including ketamine, methamphetamine, cocaine, cannabis, ecstasy, Dormicum/Halcion/Erimin 5/non-prescription hypnotic drugs, heroin, cough suppressant (not for curing cough), amyl nitrite (popper), GHB/GBL (γ-hydroxybutyrate), 5-methoxy-N, N-diisopropyltryptamine (Foxy), and mephedrone
aPositive Attitude Scale, three items, Cronbach’s alpha: 0.648, one factor was identified by explanatory factor analysis, explaining for 61.6% of the total variance. Higher score of the scale indicated more positive attitudes toward PrEP
Negative Attitude Scale, five items, Cronbach’s alpha: 0.747, one factor was identified by explanatory factor analysis, explaining for 56.6% of the total variance. Higher score of the scale indicated more negative attitudes toward PrEP
Associations between background characteristics and willingness to take once-daily oral pill as PrEP in the next six months (among GBMSM with experience of SDU in the past year who were not on PrEP, n = 70)
| Row% | OR (95%CI) | |
|---|---|---|
| Age group | ||
| 18–30 | 53.2 | 1.0 |
| 31–40 | 57.8 | 0.55 (0.19, 1.59) |
| > 40 | 77.8 | 1.40 (0.25, 7.93) |
| Highest educational level attained | ||
| Senior high or below | 83.3 | 1.0 |
| College or above | 61.5 | 0.32 (0.08, 1.25)† |
| Current marital status | ||
| Currently single | 69.0 | 1.0 |
| Married/cohabited with a man | 64.3 | 0.81 (0.29, 2.22) |
| Monthly personal income (HK$) | ||
| < 10,000 | 75.0 | 1.0 |
| 10,000-19,999 | 74.1 | 0.95 (0.20, 4.55) |
| 20,000-39,999 | 63.6 | 0.58 (0.12, 2.80) |
| 40,000 and above | 44.4 | 0.27 (0.04, 1.70) |
| Current employment status | ||
| Full-time | 67.9 | 1.0 |
| Part-time/unemployed/retired/ students | 64.7 | 0.87 (0.27, 2.73) |
| Sexual orientation | ||
| Homosexual | 66.2 | 1.0 |
| Bisexual | 80.0 | 2.05 (0.22, 19.43) |
| Channels of recruitment | ||
| Outreach in gay venues | 73.3 | 1.0 |
| Online recruitment | 68.4 | 0.79 (0.21, 2.99) |
| Peer referral | 58.8 | 0.52 (0.12, 2.32) |
| HIV testing in the last 12 months | ||
| No | 50.0 | 1.0 |
| Yes | 72.0 | |
| Other HIV prevention services in the last 12 months (e.g., condom distribution, peer education, pamphlet and lectures) | ||
| No | 73.9 | 1.0 |
| Yes | 63.8 | 0.62 (0.21, 1.88) |
| Drug cessation/rehabilitation services provided by governmental organizations | ||
| No | 69.1 | 1.0 |
| Yes | 0.0 | N.A. |
| Drug cessation/rehabilitation services provided by non-governmental organizations | ||
| No | 68.3 | 1.0 |
| Yes | 57.1 | 0.62 (0.13, 3.04) |
| History of other sexually transmitted infections | ||
| No | 68.0 | 1.0 |
| Yes | 65.0 | 0.87 (0.29, 2.61) |
| Had had anal intercourse with regular male sex partners (RP) | ||
| No | 68.8 | 1.0 |
| Yes | 66.7 | 0.91 (0.27, 3.02) |
| Had had anal intercourse with non-regular male sex partners (NRP) | ||
| No | 57.1 | 1.0 |
| Yes | 68.3 | 1.61 (0.33, 7.89) |
OR: crude odds ratios
OR and 95% were bold for variables with p < 0.05
† 0.05 < P < 0.10, * P < 0.05
N.A. Not applicable
Factors associated with willingness to take once-daily oral pill as PrEP in the next six months (among GBMSM with experience of SDU in the past year and were not on PrEP, n = 70)
| OR (95%CI) | AOR (95%CI) | |
|---|---|---|
| Poly-use of psychoactive substances during SDU the past year | ||
| No | 1.0 | |
| Yes | 2.02 (0.58, 7.01) | – |
| Time since the first episode of SDU | ||
| < 1 year | 1.0 | |
| 1–2 years | 1.00 (0.21, 4.77) | |
| 3–5 years | 1.14 (0.25, 5.33) | |
| > 5 years | 0.59 (0.18, 1.96) | – |
| Frequency of SDU in the past year | ||
| 1 episode/month | 1.0 | |
| 1–2 episodes/month | 0.81 (0.25, 2.67) | |
| ≥ 3 episodes/month | 1.33 (0.39, 4.58) | |
| Condomless anal intercourse in the past year | ||
| No | 1.0 | |
| Yes | 0.88 (0.32, 2.40) | |
| Positive Attitude Scale | ||
| Negative Attitude Scale | 1.16 (0.91, 1.47) | – |
| People who are important to you will support you to use PrEP | ||
| Disagree/neutral | 1.0 | 1.0 |
| Agree | ||
| In general, you are confident in taking PrEP every day in the next six months | ||
| Strongly disagree/disagree/neutral | 1.0 | 1.0 |
| Agree/strongly agree | ||
| Depressive symptoms | ||
| No clinical depressive symptoms | 1.0 | |
| Presence of clinical depressive symptoms | 0.88 (0.32, 2.40) | |
| Anxiety | ||
| No/mild/anxiety | 1.0 | |
| Severe anxiety | 0.46 (0.08, 2.45) | |
OR: crude odds ratios
AOR: multivariate odds ratios obtained by multivariate logistic regression using variables in Tables 3 and 4 that were found to be statistically significant in the univariate analysis as candidates
95%CI 95% confidence interval
OR, AOR and 95% were bold for variables with p < 0.05
*** P < 0.001, −--: not considered in the model